The Added Value of a Third Supervised Training Session to a Standard 12-week Rehabilitation Program After Breast Cancer: Pilot Study
NCT ID: NCT05455385
Last Updated: 2022-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2021-06-05
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of a Modern Educational Intervention in Breast Cancer Patients
NCT03351075
Patient-centered Breast Cancer Teleprehabilitation
NCT05782504
Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors
NCT01113554
Prehabilitation and RecOVERy From Surgery for Breast Cancer Study
NCT05901142
Telerehabilitation in Survival Breast Cancer Patients
NCT05720858
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
standard 12-week rehabilitation program
The standard program consisted of 1 session in the fitness room and 1 session in the sports hall/week during 12 weeks.
Hydrotherapy group
standard 12-week rehabilitation program
The standard program consisted of 1 session in the fitness room and 1 session in the sports hall/week during 12 weeks.
extra session hydrotherapy
The hydrotherapy group receives 1.5h additional hydrotherapy/week in addition to the standard program.
Ground exercise group
standard 12-week rehabilitation program
The standard program consisted of 1 session in the fitness room and 1 session in the sports hall/week during 12 weeks.
extra session ground exercises
The ground exercise group, receives 1.5h ground exercises/week in addition to the standard program.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standard 12-week rehabilitation program
The standard program consisted of 1 session in the fitness room and 1 session in the sports hall/week during 12 weeks.
extra session hydrotherapy
The hydrotherapy group receives 1.5h additional hydrotherapy/week in addition to the standard program.
extra session ground exercises
The ground exercise group, receives 1.5h ground exercises/week in addition to the standard program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* possible (neo)adjuvant chemotherapy and radiotherapy have been completed
* hormone and/or immunotherapy may still be ongoing
Exclusion Criteria
* oncological unstable disease
* terminal patients
* severe physical disabilities
* severe mental disabilities
* pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
An De Groef, Prof
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Leuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
s63338
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.